Net worth tracking
Login Sign Up
  • All Opinions
  • Top Picks
  • Discover
  • Companies
  • Experts
WATCH LIST
Home » Daily

U.S. markets soar on phase 1 vaccine news

Allan TongAllan Tong Posted On May 18, 2020
0
235 Views
0
0
Shares
  • Share On Facebook
  • Tweet It

As the TSX closed for Victoria Day, American markets soared on news from pharma, Moderna, that phase 1 test results of its Covid-19 vaccine were positive. In these early tests, the vaccine triggered in human subjects antibodies to halt the virus at levels that matched or exceeded those in people who recovered from Covid-19 naturally. A relatively small number of people were observed in phase 1, but now Moderna can test the vaccine on several hundred. If it passes phase 2, the vaccine progresses to a pool of thousands in phase 3 which could happen as soon as July.

The rest results don’t automatically mean that Moderna has created the vaccine, but it is a first positive step and puts Moderna ahead in the vaccine race. (See our weekly summary for about more the vaccine race.)

Moderna soared 20% Monday to close at $80, $4 off the day’s high. American indices stayed consistently strong, if not rising modestly throughout the session. The Dow jumped 3.85% and the Nasdaq closed at 2.44%. The Russell 2000 of small-caps rallied 6.1%. Oil also rose with WTI gaining 10% to $32 per barrel, with WCS enjoying similar gains. Other winners included American Express (7.53%), Walgreens (6.41%) and Boeing (12.87%). All Dow components rallied. The TSX reopens on Tuesday.

💉 Moderna Inc +20%
💳 American Express +7.53%
💊 Walgreen Boots Alliance +6.41%
✈ Boeing +12.87%

Post Views: 235
0
Shares
  • Share On Facebook
  • Tweet It




Trending Now
Moderna, Snap Inc. and 21 Stock and 1 ETF Top Picks (Apr 01-08)
Melisa R. H. April 9, 2021
Toronto Dominion, Dollarama Inc. and More at 52-week Highs (Mar 31 Apr 06)
Melisa R. H. April 7, 2021
Read Next

TSX catches up to Monday's U.S. rally as Wall Street gives back some

  • We're the Stock Chasers
    Hi! We are the Stock Chasers. We write about investing and finance tools we love. We’re passionate about fintech and we invest almost all our affiliate and advertising revenues into the development of Stockchase and Wealthica. We hope you enjoy the stock ideas and product reviews!
  • Join 39,652 Investors

    Winning in the Market eBook
    We deliver stock ideas to your inbox. Sign up free, get the ebook!

  • Top Reviews

    • The Ugly Truth About Identity Theft – Free Credit Report
      10
    • Questrade Review: Pros & Cons of Trading with Questrade Canada (2021)
      8.5
    • Questrade vs Others | The Review Competitors Don’t Want you to Read (2021)
      7.4
  • Popular Posts

    • Moderna, Snap Inc. and 21 Stock and 1 ETF Top Picks (Apr 01-08)
    • Toronto Dominion, Dollarama Inc. and More at 52-week Highs (Mar 31 Apr 06)
    • Planet 13 Holdings Inc., Goodfood Market Corp. and More Earnings Reports this Week (Apr 05-09)
    • 5G Stocks Are Coming -- Are You Ready?
    • 3 Underestimated Automation Stocks
  • Stock Lists

    • April Showers and Flowers: 4 Covid Vaccination Stocks...
      April 6, 2021
    • Wine and Pizza: 3 Uplifting Food Stocks
      March 30, 2021
    • 3 Underestimated Automation Stocks
      March 23, 2021
    • 5G Stocks Are Coming -- Are You Ready?
      March 16, 2021
    • 3 Overdone and Oversold Stocks
      March 10, 2021


  • Get $50 in free trades.


  • Stockchase neither recommends nor promotes any investment strategies.

    About us : Privacy & Terms : Contact us

© Stockchase Inc.
Press enter/return to begin your search